MDWD
MediWound Ltd.NASDAQHealthcare$16.81+3.77%ClosedMarket Cap: $182.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.94
P/S
10.77
EV/EBITDA
-12.81
DCF Value
$-28.58
FCF Yield
-11.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
19.2%
Operating Margin
-149.1%
Net Margin
-140.8%
ROE
-65.8%
ROA
-27.7%
ROIC
-41.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.9M | 14.9% | $-7.8M | $-7.2M | $-0.56 | — |
| FY 2025 | $17.0M | 12.6% | $-25.3M | $-23.9M | $-2.10 | — |
| Q3 2025 | $5.4M | 16.5% | $-6.5M | $-2.7M | $-0.24 | — |
| Q2 2025 | $5.7M | 23.5% | $-5.7M | $-13.3M | $-1.23 | — |
| Q1 2025 | $4.0M | 18.7% | $-5.2M | $-726.0K | $-0.07 | — |
| Q4 2024 | $5.8M | 15.5% | $-6.1M | $-3.9M | $-0.36 | — |
| FY 2024 | $20.2M | 8.8% | $-19.4M | $-30.2M | $-3.03 | — |
| Q3 2024 | $4.4M | 15.5% | $-5.1M | $-10.3M | $-0.98 | — |
| Q2 2024 | $5.1M | 8.8% | $-4.5M | $-6.3M | $-0.68 | — |
| Q1 2024 | $5.0M | 12.2% | $-3.7M | $-9.7M | $-1.05 | — |
| Q4 2023 | $5.3M | 13.5% | $-3.9M | $-1.7M | $-0.19 | — |
| FY 2023 | $18.7M | 15.8% | $-15.5M | $-6.7M | $-0.75 | — |